While Microsoft's share price has moderated from its summer peak, the technology behemoth continues to advance its artificial intelligence initiatives...

UnitedHealth Group finds itself in the political crosshairs as a U.S. congressman demands immediate explanations for the healthcare giant's planned...

A significant sell-off is rippling through equity markets, with technology and artificial intelligence stocks experiencing particularly heavy losses. Semiconductor leader...

In a surprising market development, Relmada Therapeutics witnessed its stock value drop by more than 3% during premarket trading. This...

The biotechnology sector is witnessing the emergence of a standout performer as Alnylam demonstrates remarkable momentum. The company is not...

Shares of Aclaris Therapeutics are demonstrating significant upward momentum, propelled by a confluence of positive clinical developments and robust financial...

A curious phenomenon is unfolding with The Trade Desk, where exceptional operational performance clashes with a severe stock market downturn....

Scilex shareholders are bracing for significant volatility as two major corporate events converge this week, each possessing the potential to...

As Moderna navigates its challenging transition beyond pandemic-era vaccine dominance, the biotechnology firm has secured overwhelming shareholder approval for a...

While artificial intelligence giants capture headlines, the real story often unfolds in the specialized technology enabling this revolution. Lumentum Holdings...